- Recent Funding
- Investors
- General Advance
General Advance portfolio
General Advance has 8 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Expanse's $5.3M Seed round in September 2026, alongside Standard Capital, Ritual Capital, Y Combinator and 6 others. By category, its portfolio leans toward Health and bio (3) and Fintech (2). It has co-invested with Y Combinator, Madrona and Outsiders Fund, most often Y Combinator (2 rounds).
About General Advance
What General Advance invests in
- Health and bio · 3 · 38%
- Fintech · 2 · 25%
- AI infrastructure and compute · 1 · 13%
- Sales and marketing · 1 · 13%
- Commerce and retail · 1 · 13%
- Media and content · 1 · 13%
- Legal and compliance · 1 · 13%
- Robotics and hardware · 1 · 13%
General Advance recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Seed · $5.3M | Standard Capital, Ritual Capital, Y Combinator +6 | ||
| Series A · $13M | DLA Piper, Madrona (lead), Pruven Capital +1 | ||
| Seed · $5.4M | Madrona (lead), Space VC, Outsiders Fund | ||
| Seed · $3M | Nomad Capital, Eight Capital, Team Ignite Ventures +6 | ||
| Series B+ · $40M | University of Melbourne, Khosla Ventures (lead), Shanda Group +6 | ||
| Series B+ · $20M | Dell Technologies Capital, Drive Capital, Ohio Innovation Fund +3 |
How General Advance invests
General Advance portfolio companies
EExpanse$5.3MSeed · Sep 2026
GGradial$13MSeries A · Mar 2025
SSolve Intelligence$3MSeed · Nov 2023
SSynchron$40MSeries B+ · Jun 2021
IImmuta$20MSeries B+ · Jun 2018
KKairon Healthbacker
Ggaiiabacker
AAnduin Transactionsbacker
| Company | Round with General Advance | Total raised | Latest raise |
|---|---|---|---|
AI infrastructure and compute |
Seed · $5.3M | $5.3M | Sep 16, 2026 Seed |
Sales and marketing |
Series A · $13M | $118.4M | Jun 19, 2026 Series B+ |
Legal and compliance |
Seed · $3M | $55.5M | Dec 9, 2025 Series B+ |
Health and bio |
Series B+ · $40M | $600M | Jun 29, 2026 Series B+ |
Fintech |
Series B+ · $20M | $217M | Aug 5, 2025 Series B+ |
Health and bio |
backer | $5M | Sep 15, 2026 Seed |
HR and recruiting |
backer | $40M | May 12, 2026 Series B+ |
Fintech |
backer | undisclosed | — |
Most frequent co-investors
YY Combinator2 shared rounds · last Sep 16, 2026MMadrona2 shared rounds · last Mar 17, 2025
OOutsiders Fund2 shared rounds · last Mar 17, 2025
SScribble Ventures1 shared round · last Sep 16, 2026
SStandard Capital1 shared round · last Sep 16, 2026PPXN Ventures1 shared round · last Sep 16, 2026
RRobinhood Ventures1 shared round · last Sep 16, 2026
AAIP Seed1 shared round · last Sep 16, 2026
CCrane Venture Partners1 shared round · last Sep 16, 2026
RRitual Capital1 shared round · last Sep 16, 2026
TTwenty Two Ventures1 shared round · last Sep 16, 2026
PPruven Capital1 shared round · last Mar 17, 2025
Similar investors
DDuquesne Family Office8 companies · 4 deals in 12 mo
KKorea Credit Guarantee Fund8 companies · 4 deals in 12 mo
NNRW.BANK8 companies · 4 deals in 12 mo
TThe Column Group8 companies · 4 deals in 12 mo
TTransformation Capital8 companies · 4 deals in 12 mo
AAsabys Partners8 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 6 rounds on Recent Funding that name General Advance. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists General Advance, which is a subset of its real portfolio. API: /api/v1/investors/general-advance (get a free API key). More: the most active VC firms and new venture capital funds.